The mRNA expression of cancer-related molecules, including those within the HGF/MET signaling pathway, were determined by microarray analysis, and compared between non-metastatic CRTC2 and metastatic CRTC2 (liver metastasis: CRTC2-LV) (Figure 2A). The gene discussed is MET; the disease is cancer.